Radiomics
Insight-based
decision making

Diseases and
therapeutic areas

Industry
and Pharma

Healthcare
professionals

Scientific
researchers

About Radiomics


Radiomics is a next generation Liege-based imaging CRO built upon the unparallel experience of its founders, pioneers of the radiomics science.

Radiomics focuses on AI powered healthcare, with a unique expertise in Radiomics, Deep Learning & Federated Learning applied to oncology and other therapeutic areas. Through our proprietary advanced image analysis technology, we aim to unravel the gold mine of hidden data information embedded in standard medical images.

Our final goal is to support insight-based decision making for optimizing pharmaceutical and biotech companies’ clinical trials and drug development studies and for providing clinicians with a patient-centered approach based on personalized medicine. With this aim, Radiomics’ R&D team is continuously working on new solutions, in collaboration with multiple national and international partners.

We can help you

optimize

Optimize

Your clinical trials (in terms of casts and time)
detect

Detect

The subtlest signals of drugs efficacy and safety risk
facilitate

Facilitate

Your crucial
go / no-go
decisions
identify

Identify

Patients likely to respond to your treatment
strenghten

Strenghten

Your points
in pay for outcome scenarios

Why Radiomics

Experience

Our scientists and clinicians are the ones who invented radiomics and have unparalleled experience and international recognition in this AI field.

Outreach

Radiomics has clients and partners in the EU, the US, Africa and Australia. Permanent presence in North America and China are in our plans for the near future.

IP Portfolio

Radiomics' comprehensive IP portfolio includes both granted and pending international (EU/US) patents.

People

Radiomics' team is composed of a multicultural and multidisciplinary set of people, specialized in a broad range of domains always enthusiastic in addressing clients and partner's needs. 

Publications

Radiomics has numerous publications in high impact journals such as Nature Reviews, Clinical Oncology, Annals of Oncology and many more. 

Latest news

  • May 19th, 2021

Visite de Mathieu Michel, Secrétaire d’Etat à la Digitalisation


La société Radiomics est heureuse et fière d’annoncer la visite, ce 19 mai 2021, de Monsieur Mathieu Michel, Secrétaire d’Etat fédéral belge à la Digitalisation, chargé de la Simplification administrative, de la Protection de la vie privée et de la Régie des Bâtiments.

  • May 3rd, 2021

Radiomics Opens its first North American office in Toronto, Ontario


Radiomics is pleased to announce the official opening of its first North American sales and support office with the support of the Walloon investment support agency AWEX. The new office, established in Toronto, Ontario will kick-start the company's partnerships in the area, better accommodating pharma companies and clinicians’ needs through North America-based team members.

  • April 20th, 2021

Radiomics CEO Wim Vos guest at Tekna Talks


Wim Vos CEO of Radiomics guest at Tekna Talks: Drug discovery – from airflow around a bobsleigh to airflow in the lungs.